<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00695942</url>
  </required_header>
  <id_info>
    <org_study_id>0708115</org_study_id>
    <secondary_id>2007-A01448-45</secondary_id>
    <secondary_id>DGS 2008-0167</secondary_id>
    <nct_id>NCT00695942</nct_id>
  </id_info>
  <brief_title>Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease</brief_title>
  <acronym>AngioPred</acronym>
  <official_title>Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease: Role of Angiogenic Factors, Hemostasis and Uterine Artery Doppler</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ARGOS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association de la Vallée de l'Ondaine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Venous thromboembolic (VTE) disease is the first cause of maternal mortality in the world.
      Some other pregnancy pathologies called Placental Vascular Pathologies (PVP) are linked to
      VTE by biological thrombophilia and are the principal cause of perinatal mortality. the
      identification of predictive factors of risk of occurrence or recurrence of two pathologies
      could enable us to propose an appropriate monitoring of patients at risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Main aim: To evaluate echographic, doppler and biological markers in a prospective manner as
      a potential predictive factor of risk of PVP and VTE.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sFlt1/plGF ratio</measure>
    <time_frame>20, 24, 28, 32, 36 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>SFlt1/PlGF ratio as predictive threshold to develop a PVP and/or a VTE</measure>
    <time_frame>20, 24, 28, 32, 36 SA</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>thrombin generation test (TGT) as potential predictive factor risck oj PVP and VTE</measure>
    <time_frame>20, 24, 28, 32 and 36 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sEng, rTFPI, D-Dimer, uCRP, PP13 as potential predictive factor of risk of PVP and or VTE</measure>
    <time_frame>20, 24, 28, 32 and 36 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>echographic data as potential predictive factors of VTE and or PVP</measure>
    <time_frame>22 and 32 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Placental Vascular Pathologies</condition>
  <condition>Venous Thromboembolism Diseases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>pregnancy women</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma and serum samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        community sample
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  previous history of one or more PVC episodes (preeclampsia, HELLPs, retroplacental
             hematoma, vascular IUGR&lt;10th percentile, recurrence miscarriage &gt;2, unexplained IUFD
             or IUFD after abruption placentae, eclampsia.

          -  Previous history of personal VTE

          -  Diabete (treated with diet or insulin)

          -  chronic hypertension

          -  chronic renal pathology

          -  lupus

          -  obesity

          -  Antihopholipids syndrome

          -  early and late pregnancy (&lt;18 years, &gt;38 years)

          -  family history of cardiovascular disease of VTE

          -  known biological thrombophilia without any personal past history of PVC or VTE

        Exclusion Criteria:

          -  Multiple pregnancy

          -  past history of in utero fetal death due to congenital malformations, rhesus
             incompatibility or an infection

          -  previous history of IUGR which etiology was a chromosomal, genic or infectious anomaly
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Céline CHAULEUR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service d'Hématologie - CHU de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de gynécologie Obstétrique</name>
      <address>
        <city>Nîmes</city>
        <zip>30000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Gynécologie Obstétrique - CHU Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2008</study_first_submitted>
  <study_first_submitted_qc>June 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2008</study_first_posted>
  <last_update_submitted>May 16, 2012</last_update_submitted>
  <last_update_submitted_qc>May 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>preeclampsia</keyword>
  <keyword>eclampsia</keyword>
  <keyword>retroplacental hematoma</keyword>
  <keyword>vascular IUGR</keyword>
  <keyword>IUFD</keyword>
  <keyword>VTE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

